We are delighted to announce that we are building on our existing relationship with @medicinesdiscoverycatapult and have joined their collaborator network. In this role, we assist companies in developing a compelling ‘investor prospectus’ for them to maximise their chance of successfully securing Series A funding.

These companies are experts in their development compound or product, but do they have robust evidence to demonstrate to investors that they can answer the following key questions;

  • What is the size of the market?
  • What is the strength of current and future competitors?
  • What is the unmet clinical need?
  • What do Thought Leaders think of your target product profile?
  • What is your peak year sales forecast and how many years post launch will that be?

7i Group can provide evidence-based scientific, medical and commercial insights to answer all of these key questions. The 7i Group team has extensive experience in the biopharmaceutical industry, including a wealth of knowledge in disease area landscaping and primary market research.

To find out more, check out https://7i-group.com and Collaborators at Medicines Discovery Catapult

#seriesafunding #investorpropspectus #marketresearch #grantapplications #science #scientificinsights